Functional balance between neuraminidase and haemagglutinin in influenza viruses

Clinical Microbiology and Infection

Volumn 22, Issue 12, 2016, Pages 975-983

  Gaymard, A ^a,b   Le Briand, N ^a   Frobert, E ^a,b   Lina, B ^a,b   Escuret, V ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Antiviral resistance; Haemagglutinin; Haemagglutinin Neuraminidase balance; Host adaptation; Influenza viruses; Neuraminidase

Indexed keywords

ANTIVIRUS AGENT; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; INFLUENZA VIRUS HEMAGGLUTININ; SIALIDASE; VIRAL PROTEIN;

ADAPTATION; ANTIVIRAL RESISTANCE; EVOLUTION; HOST; HUMAN; INFLUENZA; INFLUENZA A (H1N1); NONHUMAN; PRIORITY JOURNAL; REVIEW; GENETICS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PROTEIN CONFORMATION; SEASON;

DRUG RESISTANCE, MULTIPLE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; NEURAMINIDASE; PROTEIN CONFORMATION; SEASONS; VIRAL PROTEINS;

EID: 85006324202     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.07.007     Document Type: Review

References (64)

1. [1] World Health Organization, WHO | Monthly Risk Assessment Summary. 2015, WHO http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/ [accessed 18.12.15].
2. [2] Medina, R.A., García-Sastre, A., Influenza A viruses: new research developments. Nat Rev Microbiol 9 (2011), 590–603.
3. [3] CIDRAP. Avian Flu Scan. CIDRAP n.d. http://www.cidrap.umn.edu/news-perspective?key=&page=1&f[0]=field_related_topics%3A49 [accessed 17.08.15].
4. [4] Harris, A., Cardone, G., Winkler, D.C., Heymann, J.B., Brecher, M., White, J.M., et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci 103 (2006), 19123–19127.
5. [5] Moulès, V., Terrier, O., Yver, M., Riteau, B., Moriscot, C., Ferraris, O., et al. Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology 414 (2011), 51–62.
6. [6] Skehel, J.J., Wiley, D.C., Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69 (2000), 531–569.
7. [7] Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., et al. New world bats harbor diverse influenza A viruses. PLoS Pathog, 9, 2013, e1003657.
8. [8] Russell, R.J., Haire, L.F., Stevens, D.J., Collins, P.J., Lin, Y.P., Blackburn, G.M., et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443 (2006), 45–49.
9. [9] Stevens, J., Blixt, O., Glaser, L., Taubenberger, J.K., Palese, P., Paulson, J.C., et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355 (2006), 1143–1155.
10. [10] Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., Kawaoka, Y., Avian flu: influenza virus receptors in the human airway. Nature 440 (2006), 435–436.
11. [11] Van Riel, D., Munster, V.J., de Wit, E., Rimmelzwaan, G.F., Fouchier, R.A.M., Osterhaus, A.D.M.E., et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171 (2007), 1215–1223.
12. [12] Stevens, J., Blixt, O., Tumpey, T.M., Taubenberger, J.K., Paulson, J.C., Wilson, I.A., Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006), 404–410.
13. [13] Tumpey, T.M., Maines, T.R., Hoeven, N.V., Glaser, L., Solórzano, A., Pappas, C., et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 (2007), 655–659.
14. [14] Koel, B.F., Burke, D.F., Bestebroer, T.M., van der Vliet, S., Zondag, G.C.M., Vervaet, G., et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342 (2013), 976–979.
15. [15] Rott, R., Klenk, H.-D., Nagai, Y., Tashiro, M., Influenza viruses, cell enzymes, and pathogenicity. Am J Respir Crit Care Med 152 (1995), S16–S19.
16. [16] Galloway, S.E., Reed, M.L., Russell, C.J., Steinhauer, D.A., Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog, 9, 2013.
17. [17] Baumann, J., Kouassi, N.M., Foni, E., Klenk, H.-D., Matrosovich, M., H1N1 Swine influenza viruses differ from avian precursors by a higher pH optimum of membrane fusion. J Virol 90 (2016), 1569–1577.
18. [18] Suguitan, A.L., Matsuoka, Y., Lau, Y.-F., Santos, C.P., Vogel, L., Cheng, L.I., et al. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J Virol 86 (2012), 2706–2714.
19. [19] Schrauwen, E.J.A., Herfst, S., Leijten, L.M., van Run, P., Bestebroer, T.M., Linster, M., et al. The multibasic cleavage site in h5n1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol 86 (2012), 3975–3984.
20. [20] Schrauwen, E.J.A., Bestebroer, T.M., Munster, V.J., de Wit, E., Herfst, S., Rimmelzwaan, G.F., et al. Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets. J Gen Virol 92 (2011), 1410–1415.
21. [21] Klenk, H.-D., Wagner, R., Heuer, D., Wolff, T., Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res 82 (2002), 73–75.
22. [22] Wagner, R., Matrosovich, M., Klenk, H.-D., Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 12 (2002), 159–166.
23. [23] Air, G.M., Influenza neuraminidase. Influenza Other Respir Viruses 6 (2012), 245–256.
24. [24] Burmeister, W.P., Ruigrok, R.W., Cusack, S., The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J 11 (1992), 49–56.
25. [25] Hausmann, J., Kretzschmar, E., Garten, W., Klenk, H.D., N1 neuraminidase of influenza virus A/FPV/Rostock/34 has haemadsorbing activity. J Gen Virol 76:Pt 7 (1995), 1719–1728.
26. [26] Uhlendorff, J., Matrosovich, T., Klenk, H.-D., Matrosovich, M., Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses. Arch Virol 154 (2009), 945–957.
27. [27] Varghese, J.N., Colman, P.M., van Donkelaar, A., Blick, T.J., Sahasrabudhe, A., McKimm-Breschkin, J.L., Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc Natl Acad Sci U S A 94 (1997), 11808–11812.
28. [28] Baum, L.G., Paulson, J.C., The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity. Virology 180 (1991), 10–15.
29. [29] Kobasa, D., Kodihalli, S., Luo, M., Castrucci, M.R., Donatelli, I., Suzuki, Y., et al. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol 73 (1999), 6743–6751.
30. [30] Gen, F., Yamada, S., Kato, K., Akashi, H., Kawaoka, Y., Horimoto, T., Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice. Arch Virol 158 (2013), 1003–1011.
31. [31] Wagner, R., Wolff, T., Herwig, A., Pleschka, S., Klenk, H.-D., Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol 74 (2000), 6316–6323.
32. [32] Baigent, S.J., McCauley, J.W., Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res 79 (2001), 177–185.
33. [33] Hooper, K.A., Bloom, J.D., A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein. J Virol 87 (2013), 12531–12540.
34. [34] Lin, Y.P., Gregory, V., Collins, P., Kloess, J., Wharton, S., Cattle, N., et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J Virol 84 (2010), 6769–6781.
35. [35] Ferraris, O., Kessler, N., Valette, M., Lina, B., Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. Vaccine 24 (2006), 6656–6659.
36. [36] Richard, M., Erny, A., Caré, B., Traversier, A., Barthélémy, M., Hay, A., et al. Rescue of a h3n2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity. PLoS One, 7, 2012, e33880.
37. [37] Stevens, J., Blixt, O., Paulson, J.C., Wilson, I.A., Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol 4 (2006), 857–864.
38. [38] Wetherall, N.T., Trivedi, T., Zeller, J., Hodges-Savola, C., McKimm-Breschkin, J.L., Zambon, M., et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41 (2003), 742–750.
39. [39] Cohen, M., Fisher, C.J., Huang, M.L., Lindsay, L.L., Plancarte, M., Boyce, W.M., et al. Capture and characterization of influenza A virus from primary samples using glycan bead arrays. Virology 493 (2016), 128–135.
40. [40] Casalegno, J.-S., Ferraris, O., Escuret, V., Bouscambert, M., Bergeron, C., Linès, L., et al. Functional balance between the hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 HA D222 Variants. PLoS One, 9, 2014.
41. [41] Xu, R., Zhu, X., McBride, R., Nycholat, C.M., Yu, W., Paulson, J.C., et al. Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol 86 (2012), 9221–9232.
42. [42] Zanin, M., Marathe, B., Wong, S.-S., Yoon, S.-W., Collin, E., Oshansky, C., et al. Pandemic swine H1N1 influenza viruses with almost undetectable neuraminidase activity are not transmitted via aerosols in ferrets and are inhibited by human mucus but not swine mucus. J Virol 89 (2015), 5935–5948.
43. [43] Benton, D.J., Martin, S.R., Wharton, S.A., McCauley, J.W., Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities. J Biol Chem 290 (2015), 6516–6521.
44. [44] Matrosovich, M., Zhou, N., Kawaoka, Y., Webster, R., The surface glycoproteins of h5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 73 (1999), 1146–1155.
45. [45] Yen, H.-L., Liang, C.-H., Wu, C.-Y., Forrest, H.L., Ferguson, A., Choy, K.-T., et al. Hemagglutinin–neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A 108 (2011), 14264–14269.
46. [46] Glaser, L., Stevens, J., Zamarin, D., Wilson, I.A., García-Sastre, A., Tumpey, T.M., et al. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 79 (2005), 11533–11536.
47. [47] Gerlach, T., Kühling, L., Uhlendorff, J., Laukemper, V., Matrosovich, T., Czudai-Matwich, V., et al. Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. Vaccine 30 (2012), 7348–7352.
48. [48] Duan, S., Govorkova, E.A., Bahl, J., Zaraket, H., Baranovich, T., Seiler, P., et al. Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses. Nat Commun, 5, 2014, 5029.
49. [49] Rameix-Welti, M.-A., Enouf, V., Cuvelier, F., Jeannin, P., van der Werf, S., Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog, 4, 2008, e1000103.
50. [50] Fereidouni, S.R., Beer, M., Vahlenkamp, T., Starick, E., Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March–September 2009. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, 14, 2009.
51. [51] Koel, B.F., Mögling, R., Chutinimitkul, S., Fraaij, P.L., Burke, D.F., van der Vliet, S., et al. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. J Virol 89 (2015), 3763–3775.
52. [52] Pizzorno, A., Abed, Y., Boivin, G., Influenza drug resistance. Semin Respir Crit Care Med 32 (2011), 409–422, 10.1055/s-0031-1283281.
53. [53] World Health Organization, WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. 2010, WHO, Geneva.
54. [54] Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N.A., Klenk, H.-D., Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 77 (2003), 8418–8425.
55. [55] Wong, D.D.Y., Choy, K.-T., Chan, R.W.Y., Sia, S.F., Chiu, H.-P., Cheung, P.P.H., et al. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation. J Virol 86 (2012), 10558–10570.
56. [56] Yang, J.-R., Huang, Y.-P., Chang, F.-Y., Hsu, L.-C., Huang, H.-Y., Pan, Y.-T., et al. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009–2011. J Med Virol 85 (2013), 379–387.
57. [57] Ferraris, O., Lina, B., Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol Off Publ Pan Am Soc Clin Virol 41 (2008), 13–19.
58. [58] Gubareva, L.V., Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 103 (2004), 199–203.
59. [59] Meijer, A., Lackenby, A., Hungnes, O., Lina, B., van-der-Werf, S., Schweiger, B., et al. Oseltamivir-resistant influenza virus A(H1N1), Europe, 2007–08 season. Emerg Infect Dis 15 (2009), 552–560.
60. [60] Escuret, V., Ferraris, O., Lina, B., The antiviral resistance of influenza virus. Therapy 8 (2011), 741–762.
61. [61] Behera, A.K., Basu, S., Cherian, S.S., Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding. Gene 557 (2015), 19–27.
62. [62] Ginting, T.E., Shinya, K., Kyan, Y., Makino, A., Matsumoto, N., Kaneda, S., et al. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J Virol 86 (2012), 121–127.
63. [63] Wu, W.L., Lau, S.-Y., Chen, Y., Wang, G., Mok, B.W.-Y., Wen, X., et al. The 2008–2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses. Antiviral Res 93 (2012), 144–153.
64. [64] Gamblin, S.J., Skehel, J.J., Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285 (2010), 28403–28409.